L ow-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.

In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and ...

The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster ...

The GoodRx for Weight Loss telemedicine subscription is available for an introductory rate of $39 per month through January 2026, with a standard price of $119 beginning on Feb. 1, 2026. Medications ...

Constipation is a common but manageable side effect of Ozempic, a medication for diabetes and weight loss. It often occurs in ...

"Ozempic 2.0" has been floating around online, as a trending nickname for the next generation of weight loss drugs that are in the works.

Lilly's Zepbound price cuts ranged from $50 to $100, depending on the dosage, for consumers who pay cash via the drugmaker's ...

The manufacturers of Ozempic and Mounjaro are creating oral weight loss medications that could change treatment methods.